A detailed history of Cormorant Asset Management, LP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 75,000 shares of LNTH stock, worth $7.65 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
75,000
Previous 75,000 -0.0%
Holding current value
$7.65 Million
Previous $4.67 Million 28.98%
% of portfolio
0.46%
Previous 0.27%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $4.17 Million - $5.84 Million
75,000 New
75,000 $4.65 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.01B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.